Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-02-25 @ 6:44 PM
Study NCT ID:
NCT01520558
Status:
UNKNOWN
Last Update Posted:
2017-06-29
First Post:
2012-01-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CNDO-109-AANK for AML in First Complete Remission (CR1)
Sponsor:
Coronado Biosciences, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02
Completion Date Type:
ESTIMATED
First Submit Date:
2012-01-24
First Submit QC Date:
None
Study First Post Date:
2012-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-18
Results First Submit QC Date:
None
Results First Post Date:
2017-06-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-30
Last Update Post Date:
2017-06-29
Last Update Post Date Type:
ACTUAL